News Focus
News Focus
icon url

Dr Bala

03/20/22 6:57 PM

#452828 RE: jondoeuk #452826

Again, pontification upon pontification.
icon url

biosectinvestor

03/20/22 7:12 PM

#452833 RE: jondoeuk #452826

No, you’re wrong about post hoc. I take my dd seriously. You might try. I am not going to waste my time proving it again and again when it makes no difference to the same posters.

I did not change the goal post, I said exactly what it is and what makes it unique. Those are the qualities that are most spectacular about DCVax. It is personalized and it is dendritic cell focused, so it operates by definition as a vaccine and identifies the specific antigens in the patients specific tumor. Because Pravin tumors are so complex and specific to different patients, this seems to be a useful approach and clearly it has taken an incredible effort and thought process to get to this stage.
icon url

sentiment_stocks

03/21/22 10:17 AM

#452929 RE: jondoeuk #452826

Again, it's in black and white. Read some of the filings.


Links and quotes, please (that’s your usual MO). Prove the SAP is ad hoc with quotes from their SEC filings.